First Patient Enrolled In W. L. Gore & Associates, Inc. EXCLUDER Iliac Branch Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced that Brian Peterson, MD, from Saint Louis University, enrolled the first patient in the Gore EXCLUDER Iliac Branch Clinical Study, a prospective, multi-center, non-randomized, single-arm study designed to assess the safety and effectiveness of the GORE® EXCLUDER® Iliac Branch Endoprosthesis for treatment of patients with Common Iliac Artery Aneurysms (CIAA) or Aorto-Iliac Aneurysms (AIA). The patient was treated at St. Anthony’s Medical Center, in St. Louis, Missouri.

Help employers find you! Check out all the jobs and post your resume.

Back to news